Patent Issued for Compositions and methods for detecting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A and Influenza B (USPTO 12195811).

Roche Molecular Systems Inc. has been issued a patent for detecting SARS-CoV-2, Influenza A, and Influenza B in biological samples. The patent provides methods for rapid and simultaneous detection of these viruses using real-time reverse-transcription polymerase chain reaction (RT-PCR). The need for accurate differentiation of these infections is crucial for medical decision-making and infection control efforts. The patent outlines specific primers, probes, and kits designed for this purpose. [Extracted from the article]